Prostate cancer stem cells: the role of CD133

J Yang, O Aljitawi, P Van Veldhuizen - Cancers, 2022 - mdpi.com
Simple Summary The current theory of the prostate cancer stem cell (PCSC) may help us
understand cancer recurrence and treatment failure of prostate cancer, and CD133 is one of …

The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis

ZN Lei, QX Teng, J Koya, Y Liu, Z Chen… - Frontiers in …, 2024 - frontiersin.org
The connections between cancer stem cells (CSCs) and epithelial-mesenchymal transition
(EMT) is critical in cancer initiation, progression, metastasis, and therapy resistance, making …

Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 …

C Tatar, CB Avci, E Acikgoz, G Oktem - Biochemical and Biophysical …, 2023 - Elsevier
Cancer stem cells (CSCs) are the most important cause of cancer treatment failure.
Traditional cancer treatments, such as chemotherapy and radiotherapy, damage healthy …

The molecular biology of prostate cancer stem cells: from the past to the future

Y Zhou, T Li, M Jia, R Dai, R Wang - International Journal of Molecular …, 2023 - mdpi.com
Prostate cancer (PCa) continues to rank as the second leading cause of cancer-related
mortality in western countries, despite the golden treatment using androgen deprivation …

“Double hit” strategy: Removal of sialic acid from the dendritic cell surface and loading with CD44+/CD24-/low cell lysate inhibits tumor growth and metastasis by …

E Acikgoz, F Duzagac, U Guven, G Yigitturk… - International …, 2022 - Elsevier
Cancer stem cells (CSCs), which represent the root cause of resistance to conventional
treatments, recurrence, and metastasis, constitute the critical point of failure in cancer …

Biomolecular fingerprints of the effect of zoledronic acid on prostate cancer stem cells: Comparison of 2D and 3D cell culture models

G Güler, E Acikgoz, G Mukhtarova, G Oktem - Archives of Biochemistry and …, 2024 - Elsevier
Revealing the potential of candidate drugs against different cancer types without disrupting
normal cells depends on the drug mode of action. In the current study, the drug response of …

Signaling pathways and targeted therapies for stem cells in prostate cancer

M Giridharan, V Rupani, S Banerjee - ACS Pharmacology & …, 2022 - ACS Publications
Prostate cancer (PCa) is one of the most frequently occurring cancers among men, and the
current statistics show that it is the second leading cause of cancer-related deaths among …

Flavokawain a reduces tumor-initiating properties and stemness of prostate cancer

L Song, M Mino, J Yamak, V Nguyen, D Lopez… - Frontiers in …, 2022 - frontiersin.org
We have previously demonstrated the in vivo chemopreventive efficacy of flavokawain A
(FKA), a novel chalcone from the kava plant, in prostate carcinogenesis models. However …

Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics

MC Borlongan, H Wang - Frontiers in Cell and Developmental Biology, 2023 - frontiersin.org
Tumorigenic cancer stem cells (CSCs) represent a subpopulation of cells within the tumor
that express genetic and phenotypic profiles and signaling pathways distinct from the other …

[HTML][HTML] Low magnetic field exposure alters prostate cancer cell properties

S Lange, JM Inal, I Kraev, DA Dart, P Uysal-Onganer - Biology, 2024 - mdpi.com
Simple Summary The effects of magnetic fields on health and disease have been subject to
considerable research interest for the past few decades but still remain relatively poorly …